⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGM

IOVA

Iovance Biotherapeutics, Inc.

Healthcare · Biotechnology

8.43USD

-0.2700 (-3.10%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 8.43
P/E—
Dvd Ind Yld—
P/B5.35
P/S12.1
Curr EV/T12M EBITDA-14.2
Mkt Cap (USD)3.9B
Curr EV (USD)3.7B
2)

Per Share Data

EPS T12M-201.77
DPS—
Bk Val Per Sh1.63
Rev/Sh721.85
Cash/Sh0.66
Curr Shares Out453.0M
FCF/Sh-658.38
3)

Cash Flow Analysis

P/CF-14.9
Curr P/FCF-13.3
CF/NI0.9
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-81.3%
Eff Interest Rate-0.0%
4)

Growth Potential

Dil EPS 1Y Gr14.8%
Cap 1Y Gr-1.7%
BPS 1Y Gr-20.2%
R&D To Sales82.4%
Retention Rate100.0%
Rev 1Y Gr60.6%
FCF 1Y Gr7.6%
Assets 1Y Gr0.3%
5)

Profitability

EBITDA-0.3B
EBIT-0.3B
Operating Margin-92.7%
Pretax Margin-90.4%
Net Margin-89.1%
ROA-31.8%
ROE-40.4%
ROC-38.0%
Asset Turnover0.36
6)

Structure

Current Ratio4.35
Quick Ratio3.74
Debt/Assets5.0%
Debt/Com Eq6.3%
Net Debt/EBITDA0.23
Tot Debt/Capital5.9%
Gross Margin48.4%
EBIT/Int Exp45,146.7

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.